Dr. Éric Turcotte, MD
Claim this profileCentre de recherche du CHUS
Studies Contagious Diseases
Studies Infectious Diseases
6 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Éric Turcotte, MD is currently running
[225Ac]-FPI-2068
for Cancer
This is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and pharmacokinetics (PK) of \[225Ac\]-FPI-2068, \[111In\]-FPI-2107, and FPI-2053 in metastatic and/or recurrent solid tumors (HNSCC, NSCLC, mCRC, PDAC).
Recruiting1 award Phase 16 criteria
Afternoon vs Morning Exercise
for Prediabetes
Exercise is well-known to improve skeletal muscle energy metabolism and is an established intervention to improve muscle insulin sensitivity and to counter the development of type 2 diabetes (T2D). However, given the 24h rhythmicity in substrate metabolism previously observed in healthy, lean men and the lack of such rhythmicity in men with insulin-resistance, the investigator hypothesize that appropriate timing of exercise training can maximize the metabolic health effects of exercise. Indeed, a preliminary study in humans revealed that afternoon high-intensity interval training (HIIT) exercise was more effective than morning exercise in improving 24h blood glucose levels in men with T2D. Another recent study in mice showed that the time of day is a critical factor in augmenting the beneficial effects of exercise on the skeletal muscle metabolome as well as on whole-body energy homeostasis. However, human studies that specifically target the impact of timing of exercise training on glucose homeostasis and metabolic health are scarce and the potential underlying mechanisms largely unknown. The overarching goals of this project is to improve 24-hour rhythmicity of metabolism in men and women with prediabtes by appropriate timing of exercise and to assess its effect on metabolic health and immune response. Acute and prolonged exercise interventions timed in the morning vs late afternoon will be carried out in individuals with prediabetes to determine whether acute exercise in the afternoon and prolonged exercise training in the afternoon can improve peripheral insulin sensitivity, compared to exercise in the morning, and positively affect adipose tissue dietary fatty acid storage and partitioning of dietary fatty acids in skeletal muscles.
Recruiting1 award N/A4 criteria
More about Éric Turcotte, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Éric Turcotte, MD has experience with
- 18F-sodium Fluoride
- 68Ga-DOTA-TATE
- 4FMFES
- FPI-2053
- [225Ac]-FPI-2068
- [111In]-FPI-2107
Breakdown of trials Éric Turcotte, MD has run
Contagious Diseases
Infectious Diseases
Infections
Bone Tumors
Arthritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Éric Turcotte, MD specialize in?
Éric Turcotte, MD focuses on Contagious Diseases and Infectious Diseases. In particular, much of their work with Contagious Diseases has involved treating patients, or patients who are undergoing treatment.
Is Éric Turcotte, MD currently recruiting for clinical trials?
Yes, Éric Turcotte, MD is currently recruiting for 4 clinical trials in Sherbrooke Quebec. If you're interested in participating, you should apply.
Are there any treatments that Éric Turcotte, MD has studied deeply?
Yes, Éric Turcotte, MD has studied treatments such as 18F-sodium fluoride, 68Ga-DOTA-TATE, 4FMFES.
What is the best way to schedule an appointment with Éric Turcotte, MD?
Apply for one of the trials that Éric Turcotte, MD is conducting.
What is the office address of Éric Turcotte, MD?
The office of Éric Turcotte, MD is located at: Centre de recherche du CHUS, Sherbrooke, Quebec J1H 5N4 Canada. This is the address for their practice at the Centre de recherche du CHUS.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.